Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 15 is a 74 amino acid transmembrane protein with one transmembrane domain, encoded by the SMIM15 gene located at 5q12.1. Expression of SMIM15 is ubiquitous but highest in the prostate. Its function is currently not well understood, but it is known to interact with PBX4, a transcription factor involved in development. Clinically, deletions affecting the SMIM15 locus are linked to mental retardation, ocular defects, and possibly influence on caries susceptibility. The protein undergoes several post-translational modifications including sumoylation, glycation, and phosphorylation, but its precise biological role and relevance as a drug target remain to be established[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 15 (SMIM15).